Double maintains 3 strategies that include ARQT - Arcutis Biotherapeutics, Inc.
Current Value
$16.621 Year Return
Current Value
$16.621 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 47.77% | $5.66B | 0.35% |
CPRJ | 43.45% | $48.98M | 0.69% |
GNOM | 43.28% | $57.10M | 0.5% |
PTH | 41.99% | $115.04M | 0.6% |
PINK | 41.25% | $145.31M | 0.5% |
IBB | 40.81% | $6.06B | 0.45% |
PBE | 40.52% | $240.72M | 0.58% |
ARKG | 39.45% | $1.07B | 0.75% |
EMHY | 36.28% | $463.24M | 0.5% |
IWO | 36.18% | $11.19B | 0.24% |
IWC | 35.39% | $845.76M | 0.6% |
XPH | 35.02% | $158.65M | 0.35% |
KJAN | 34.99% | $322.85M | 0.79% |
QQQJ | 34.77% | $603.97M | 0.15% |
KOMP | 34.73% | $2.03B | 0.2% |
FBT | 34.47% | $1.12B | 0.56% |
HYGV | 34.33% | $1.45B | 0.37% |
SJNK | 34.22% | $4.97B | 0.4% |
FLHY | 34.18% | $617.39M | 0.4% |
ISCG | 34.02% | $672.81M | 0.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TEM | -11.63% | $8.27B | 0.00% | 0.00% |
CBOE | -11.31% | $22.97B | +19.12% | 1.11% |
TMUS | -8.88% | $293.46B | +59.72% | 1.20% |
BTCT | -8.22% | $23.17M | +40.12% | 0.00% |
ED | -8.02% | $38.30B | +22.37% | 3.09% |
SCM | -7.07% | - | - | 11.19% |
CHD | -6.90% | $26.58B | +4.03% | 1.06% |
K | -6.85% | $28.42B | +46.73% | 2.76% |
CL | -6.52% | $73.27B | +1.70% | 2.22% |
LITB | -6.48% | $18.75M | -77.50% | 0.00% |
MNOV | -6.33% | $74.06M | +6.34% | 0.00% |
FAT | -6.16% | $54.09M | -27.63% | 13.82% |
MO | -6.12% | $98.21B | +29.23% | 6.90% |
PRPH | -6.04% | $11.61M | -93.09% | 0.00% |
VZ | -6.00% | $184.17B | +7.92% | 6.13% |
PEP | -5.94% | $201.82B | -14.67% | 3.69% |
OXBR | -5.92% | $17.42M | +107.08% | 0.00% |
KDP | -5.80% | $45.36B | +13.02% | 2.66% |
TEF | -5.79% | $26.13B | +8.43% | 6.77% |
ASPS | -5.77% | $21.91M | -67.29% | 0.00% |
SeekingAlpha
In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.
Finnhub
Once-daily, steroid-free topical treatment designed to rapidly reduce itch and proactively support long term disease controlRapid and significant improvements in disease clearance with ZORYVE cream...
SeekingAlpha
Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the prospects for its lead product Zoryve.
Finnhub
WESTLAKE VILLAGE, ORLANDO - Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced new data...
Finnhub
WESTLAKE VILLAGE, Calif., March 05, 2025 -- Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today...
Finnhub
WESTLAKE VILLAGE - Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KRYS | 39.42% | $5.43B | +11.08% | 0.00% |
RYTM | 37.68% | $3.43B | +33.44% | 0.00% |
IDYA | 36.10% | $1.61B | -59.59% | 0.00% |
BEAM | 34.93% | $2.28B | -34.56% | 0.00% |
DNLI | 34.17% | $2.12B | -30.43% | 0.00% |
BPMC | 33.62% | $5.65B | -1.75% | 0.00% |
CYTK | 33.49% | $5.10B | -34.73% | 0.00% |
OCUL | 32.62% | $1.18B | -26.70% | 0.00% |
NRIX | 32.58% | $1.05B | +6.53% | 0.00% |
RXRX | 32.47% | $2.60B | -39.15% | 0.00% |
NTLA | 31.73% | $900.60M | -68.54% | 0.00% |
PRTA | 31.54% | $692.75M | -49.71% | 0.00% |
RICK | 31.35% | $404.24M | -18.52% | 0.60% |
CRSP | 31.13% | $3.53B | -44.74% | 0.00% |
CFLT | 31.12% | $8.89B | -16.29% | 0.00% |
BARK | 31.12% | $241.38M | +2.22% | 0.00% |
EFX | 31.07% | $30.19B | -8.47% | 0.64% |
PHR | 30.93% | $1.62B | +17.09% | 0.00% |
KFY | 30.88% | $3.45B | +2.26% | 2.17% |
CELC | 30.88% | $388.75M | -40.58% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VRSK | <0.01% | $40.35B | +21.94% | 0.57% |
PARA | -0.01% | $8.00B | +0.93% | 1.68% |
CTRA | -0.02% | $22.17B | +5.88% | 2.95% |
CCEC | 0.03% | $1.14B | +9.37% | 3.06% |
JILL | 0.03% | $276.59M | -38.38% | 1.18% |
RWAY | 0.06% | $399.62M | -10.27% | 11.35% |
CYCN | 0.07% | $7.34M | -15.31% | 0.00% |
TGT | 0.08% | $47.47B | -38.77% | 4.33% |
NXTC | -0.09% | $17.21M | -63.43% | 0.00% |
LFVN | -0.09% | $204.34M | +134.92% | 0.99% |
CRI | -0.10% | $1.47B | -51.72% | 7.87% |
PPC | -0.11% | $12.31B | +53.19% | 0.00% |
PDD | 0.12% | $181.82B | +7.05% | 0.00% |
PDCO | 0.13% | $2.76B | +14.12% | 2.50% |
UUU | -0.13% | $4.21M | +21.33% | 0.00% |
SEG | 0.16% | $254.82M | -22.07% | 0.00% |
DG | 0.20% | $17.96B | -47.06% | 2.91% |
TRVG | -0.21% | $107.67M | +82.95% | 0.00% |
USM | 0.22% | $5.69B | +86.86% | 0.00% |
WRAP | -0.22% | $92.22M | -23.86% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IYK | 0.10% | $1.43B | 0.4% |
WEAT | 0.10% | $122.51M | 0.28% |
SHV | 0.10% | $19.68B | 0.15% |
BUXX | 0.15% | $229.45M | 0.25% |
UGA | 0.23% | $85.26M | 0.97% |
TBLL | -0.45% | $2.05B | 0.08% |
TFLO | -0.48% | $6.79B | 0.15% |
VRIG | 0.52% | $1.33B | 0.3% |
FLTR | -0.65% | $2.36B | 0.14% |
ULST | -0.73% | $584.04M | 0.2% |
FLRN | -0.76% | $2.77B | 0.15% |
XLP | 0.86% | $16.37B | 0.09% |
DBMF | 0.87% | $1.15B | 0.85% |
KRBN | -0.94% | $180.36M | 0.85% |
JUCY | 1.08% | $305.26M | 0.6% |
IBMO | 1.23% | $505.91M | 0.18% |
JBBB | 1.53% | $1.79B | 0.49% |
UNG | -1.82% | $456.14M | 1.06% |
CLOA | -1.85% | $779.45M | 0.2% |
BILZ | 2.05% | $720.70M | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -28.76% | $214.47M | 0.5% |
UUP | -25.01% | $332.64M | 0.77% |
BTAL | -24.72% | $392.24M | 1.43% |
VIXY | -24.42% | $195.31M | 0.85% |
TPMN | -12.51% | $33.27M | 0.65% |
TAIL | -12.36% | $83.83M | 0.59% |
MINT | -11.80% | $13.20B | 0.35% |
TBIL | -10.84% | $5.28B | 0.15% |
BIL | -8.41% | $42.20B | 0.1356% |
KMLM | -7.94% | $227.79M | 0.9% |
CTA | -7.41% | $927.03M | 0.76% |
CCOR | -6.64% | $63.91M | 1.18% |
SGOV | -6.53% | $38.60B | 0.09% |
CLOZ | -5.72% | $862.49M | 0.5% |
USFR | -4.24% | $18.45B | 0.15% |
ICLO | -3.56% | $355.46M | 0.2% |
JAAA | -2.81% | $21.90B | 0.21% |
AGZD | -2.39% | $139.24M | 0.23% |
XBIL | -2.30% | $706.56M | 0.15% |
CLOA | -1.85% | $779.45M | 0.2% |